|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Net income | |||||
| Adjustments to reconcile net income to net cash from operating activities: | |||||
| Provision credit losses | |||||
| Depreciation | |||||
| Accretion, net | |||||
| Deferred income tax (benefit) expense | |||||
| Net loss on sale of equity security | |||||
| Originations of loans held for sale | |||||
| Proceeds from sale of loans held for sale | |||||
| Net gains on sales of residential mortgage loans | |||||
| Net losses (gains) on sales of commercial loans | |||||
| Net gains on sales of SBA loans | |||||
| Loss on disposal of premises and equipment | |||||
| Loss on sale of other assets held for sale | |||||
| Earnings on bank owned life insurance | |||||
| Restricted stock expense, net of forfeitures | |||||
| Net change in: | |||||
| Accrued interest receivable and other assets | |||||
| Operating lease right-of-use asset | |||||
| Operating lease liability | |||||
| Accrued interest payable and other liabilities | |||||
| Net cash from operating activities | |||||
| Cash flows from investing activities: | |||||
| Available-for-sale securities: Maturities, prepayments and calls | |||||
| Available-for-sale securities, Purchases | |||||
| Proceeds from the sale of equity security | |||||
| Loan and lease originations and payments, net | |||||
| Purchase of loans and leases | |||||
| Proceeds from the sale of loans | |||||
| Additions to premises and equipment | |||||
| Redemption (purchase) of FRB and FHLB stock | |||||
| Purchase of other investments | |||||
| Purchase of investment- joint ventures | |||||
| Return of investment-joint ventures | |||||
| Other adjustments | |||||
| Proceeds from the sale of foreclosed assets | |||||
| Proceeds from the sale of assets held for sale | |||||
| Net cash used by investing activities | |||||
| Cash flows from financing activities: | |||||
| Net change in deposits | |||||
| Proceeds from FHLB advances and other debt | |||||
| Repayments on FHLB advances and other debt | |||||
| Net change in advances by borrowers for taxes and insurance | |||||
| Cash dividends paid | |||||
| Proceeds from exercise of stock options | |||||
| Acquisition of treasury shares surrendered upon vesting of restricted stock and exercised options for payment of taxes and exercise proceeds | |||||
| Purchase of treasury shares | |||||
| Net cash from (used by) financing activities | |||||
| Net change in cash and cash equivalents | |||||
| Beginning cash and cash equivalents | |||||
| Ending cash and cash equivalents | |||||
| Supplemental cash flow information: | |||||
| Interest paid | |||||
| Income tax paid | |||||
| Supplemental noncash disclosures: | |||||
| Transfer from loans to foreclosed assets | |||||
| Investment payable on limited partnerships | |||||
| Initial recognition of operating lease right-of-use asset | |||||
| Initial recognition of operating lease liability | |||||
Loading...